These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 22187705

  • 1. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
    Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R, Hermanova M.
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT, Cai QC, Zheng JM, Man XH, Jiang H, Song B, Jin G, Zhu W, Li ZS.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J, Centeno BA, Coppola D, Melis M, Lloyd M, Park JY, Chen DT, Malafa MP.
    Cancer; 2009 Sep 15; 115(18):4080-9. PubMed ID: 19626671
    [Abstract] [Full Text] [Related]

  • 7. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, Kayashima T, Fujita H, Ohuchida K, Ohtsuka T, Takahata S, Nakamura M, Tanaka M.
    Ann Surg Oncol; 2012 Jul 15; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF.
    World J Gastroenterol; 2015 Jun 07; 21(21):6621-30. PubMed ID: 26074700
    [Abstract] [Full Text] [Related]

  • 10. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A, Xu Y, Liu S, Jin T, Li Z, Jin H, Lin L, Lin Z.
    Exp Mol Pathol; 2014 Feb 07; 96(1):54-60. PubMed ID: 24263054
    [Abstract] [Full Text] [Related]

  • 11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
    Ben QW, Wang JC, Liu J, Zhu Y, Yuan F, Yao WY, Yuan YZ.
    Ann Surg Oncol; 2010 Aug 21; 17(8):2213-21. PubMed ID: 20162456
    [Abstract] [Full Text] [Related]

  • 14. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S, Morohashi S, Kudo Y, Akasaka H, Ogasawara H, Ono M, Takasugi K, Ishido K, Hakamada K, Kijima H.
    J Surg Oncol; 2011 Jun 01; 103(7):669-73. PubMed ID: 21360711
    [Abstract] [Full Text] [Related]

  • 15. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA, Biankin AV.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 01; 15(10):1941-7. PubMed ID: 17035403
    [Abstract] [Full Text] [Related]

  • 16. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
    Tsiambas E, Kravvaritis C, Tsounis D, Salemis NS, Niotis A, Niotis TH, Rigopoulos DN, Karameris A, Athanasiou AE, Patsouris E, Karakitsos P.
    J BUON; 2010 Oct 01; 15(1):94-100. PubMed ID: 20414934
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wen Z, Liao Q, Zhao J, Hu Y, You L, Lu Z, Jia C, Wei Y, Zhao Y.
    Ann Surg Oncol; 2014 Jan 01; 21(1):125-32. PubMed ID: 24132627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.